Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e.general practitioners and internists) are asked to document relevant data related to the budesonide/formoterole therapy in patients with COPD.
Study Type
OBSERVATIONAL
Enrollment
18,014
efficacy and tolerability of budesonide /formoterole in subjects with COPD who are treated by general practitioners and internists.
Time frame: change of a quality of life score compared to baseline by using CRQ, stratified by present therapy and severity of COPD; incidence of the occurrence of unknown, unexpected and/or rarely occurring adverse events AE under outpatient medical care conditions
to get further insight into the details of the use , dosage scheme and duration of treatment with budesonide /formoterol in this population
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.